ST
VRTX icon

Sageworth Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Sageworth Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$215K Buy
+481
New +$224K 0.01% 165
2025
Q4 		– Sell
-561
Closed -$220K – 265
2025
Q3 		$220K Buy
+561
New +$234K 0.01% 251
2024
Q3 		– Sell
-762
Closed -$357K – 129
2024
Q2 		$357K Buy
+762
New +$331K 0.02% 89
2018
Q1 		– Sell
-7
Closed -$1K – 189
2017
Q4 		$1K Buy
+7
New +$1.04K ﹤0.01% 115

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sageworth Trust's VRTX Position: Q1 2026 in Review

Sageworth Trust opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 481 shares worth $215K. The stake represents 0.01% of the portfolio and ranks #165 among its holdings. This is a return to the name: Sageworth Trust previously reported a position in VRTX as recently as Q3 2025.

Sageworth Trust first reported a position in VRTX in Q4 2017 and has held it in 4 quarters since. The position peaked at $357K in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Sageworth Trust held 481 shares of Vertex Pharmaceuticals worth $215K as of Q1 2026.
  • Vertex Pharmaceuticals was a new Sageworth Trust position in Q1 2026.
  • Vertex Pharmaceuticals made up 0.01% of Sageworth Trust's portfolio in Q1 2026, its #165 holding.
  • Sageworth Trust first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 4 quarters since.
  • Sageworth Trust's Vertex Pharmaceuticals position peaked at $357K in Q2 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Sageworth Trust's 13F filing for Q1 2026, filed 29 Apr 2026.